Bone Therapeutics (0R55) Financial Statements

2 Followers

Bone Therapeutics Financial Overview

Bone Therapeutics's market cap is currently €1.57M. The company's EPS TTM is €; its P/E ratio is 0.07; Bone Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Jun 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 0.00	€ 0.00	€ 543.00K	€ 296.00K	€ 312.00K
Gross Profit	€ 0.00	€ -196.00K	€ 543.00K	€ 296.00K	€ 987.00K
Operating Income	€ -1.32M	€ -8.27M	€ -7.04M	€ -2.32M	€ -1.19M
EBITDA	€ -1.32M	€ -4.84M	€ -6.80M	€ -2.26M	€ -864.00K
Net Income	€ 20.93M	€ -4.77M	€ -28.78M	€ -2.04M	€ -984.00K
Balance Sheet
Cash & Short-Term Investments	€ 69.00K	€ 391.00K	€ 117.00K	€ 1.85M	€ 759.00K
Total Assets	€ 3.42M	€ 4.74M	€ 9.56M	€ 29.32M	€ 19.77M
Total Debt	€ 3.81M	€ 27.73M	€ 28.52M	€ 23.79M	€ 3.52M
Net Debt	€ 3.74M	€ 27.34M	€ 28.40M	€ 18.99M	€ 11.29M
Total Liabilities	€ 5.37M	€ 31.55M	€ 32.26M	€ 26.20M	€ 26.54M
Stockholders' Equity	€ -1.96M	€ -25.07M	€ -22.91M	€ 3.53M	€ -2.67M
Cash Flow
Free Cash Flow	€ 0.00	€ 0.00	€ -3.47M	€ -1.92M	€ -12.99M
Operating Cash Flow	€ -1.05M	€ -2.23M	€ -3.47M	€ -1.91M	€ -12.78M
Investing Cash Flow	€ 29.00K	€ 31.00K	€ 6.00K	€ 1.95M	€ -204.00K
Financing Cash Flow	€ 747.00K	€ 2.48M	€ 1.74M	€ 1.04M	€ 1.17M

Currency in EUR

Bone Therapeutics Earnings and Revenue History

Income Statement >

Bone Therapeutics Debt to Assets

Balance Sheet >

Bone Therapeutics Cash Flow

Cash Flow >

Bone Therapeutics Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >